Relmada Therapeutics, Inc. (RLMD)

Looking to buy Relmada Therapeutics Inc Stock? Get the latest RLMD quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Following the last earnings report on May 12, 2026, RLMD's stock price moved — from — to —.

Relmada Therapeutics Inc. (NASDAQ:RLMD) is one of the best growth stocks under $30 to buy now. On May 12, Relmada Therapeutics reported Q1 2026 results, highlighted by positive 12-month Phase 2 data for its NDV-01 candidate, which showed a 95% complete response rate in high-risk non-muscle ...

Relmada Therapeutics (NASDAQ:RLMD) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-relmada-therapeutics-inc-stock...

The previous big move we wrote ... the stock to Equalweight from Overweight and lowered its price target. The investment firm cut its price target on the shares to $230 from $286. The analyst cited several concerns, including limits to near-term profit margin growth and modest earnings ...